Literature DB >> 28473619

NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors.

Xingguo Zhu1, Biaoru Li2, Betty S Pace2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28473619      PMCID: PMC5541881          DOI: 10.3324/haematol.2016.160788

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  Targeted therapeutic strategies for fetal hemoglobin induction.

Authors:  Vijay G Sankaran
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  Looping and interaction between hypersensitive sites in the active beta-globin locus.

Authors:  Bas Tolhuis; Robert Jan Palstra; Erik Splinter; Frank Grosveld; Wouter de Laat
Journal:  Mol Cell       Date:  2002-12       Impact factor: 17.970

3.  Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins.

Authors:  Hiromi Yamazaki; Fumiki Katsuoka; Hozumi Motohashi; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

4.  Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.

Authors:  Sima Zein; Wei Li; Valya Ramakrishnan; Tzu-Fang Lou; Sharanya Sivanand; Ashley Mackie; Betty Pace
Journal:  Exp Biol Med (Maywood)       Date:  2010-11

Review 5.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

6.  Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.

Authors:  Vijay G Sankaran; Tobias F Menne; Jian Xu; Thomas E Akie; Guillaume Lettre; Ben Van Handel; Hanna K A Mikkola; Joel N Hirschhorn; Alan B Cantor; Stuart H Orkin
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

7.  Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.

Authors:  Elizabeth R Macari; Christopher H Lowrey
Journal:  Blood       Date:  2011-04-04       Impact factor: 22.113

8.  Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:Quinone oxidoreductase1 gene.

Authors:  S Dhakshinamoorthy; A K Jaiswal
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

9.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.

Authors:  K Itoh; N Wakabayashi; Y Katoh; T Ishii; K Igarashi; J D Engel; M Yamamoto
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

10.  Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.

Authors:  Jian Xu; Daniel E Bauer; Marc A Kerenyi; Thuy D Vo; Serena Hou; Yu-Jung Hsu; Huilan Yao; Jennifer J Trowbridge; Gail Mandel; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

View more
  11 in total

1.  NRF2 mediates γ-globin gene regulation through epigenetic modifications in a β-YAC transgenic mouse model.

Authors:  Xingguo Zhu; Caixia Xi; Alexander Ward; Mayuko Takezaki; Huidong Shi; Kenneth R Peterson; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26

Review 2.  Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease.

Authors:  Xingguo Zhu; Aluya R Oseghale; Lopez H Nicole; Biaoru Li; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-23

3.  Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain.

Authors:  Biaoru Li; Xingguo Zhu; Mir A Hossain; Cameron R Guy; Hongyan Xu; Jörg Bungert; Betty S Pace
Journal:  Haematologica       Date:  2018-04-05       Impact factor: 9.941

4.  δ-Aminolevulinate induces fetal hemoglobin expression by enhancing cellular heme biosynthesis.

Authors:  Li Liu; Xingguo Zhu; Alexander Yu; Christina M Ward; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-31

5.  Loss of NRF2 function exacerbates the pathophysiology of sickle cell disease in a transgenic mouse model.

Authors:  Xingguo Zhu; Caixia Xi; Bobby Thomas; Betty S Pace
Journal:  Blood       Date:  2017-12-18       Impact factor: 22.113

Review 6.  Exploring epigenetic and microRNA approaches for γ-globin gene regulation.

Authors:  Athena Starlard-Davenport; Ashley Fitzgerald; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-22

7.  MIR29B mediates epigenetic mechanisms of HBG gene activation.

Authors:  Athena Starlard-Davenport; Alana Smith; Luan Vu; Biaoru Li; Betty S Pace
Journal:  Br J Haematol       Date:  2019-03-19       Impact factor: 6.998

Review 8.  Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option.

Authors:  Athena Starlard-Davenport; Qingqing Gu; Betty S Pace
Journal:  Mol Diagn Ther       Date:  2022-05-12       Impact factor: 4.476

Review 9.  Sickle cell disease: progress towards combination drug therapy.

Authors:  Betty S Pace; Athena Starlard-Davenport; Abdullah Kutlar
Journal:  Br J Haematol       Date:  2021-01-20       Impact factor: 6.998

10.  Significance of heme oxygenase-1(HMOX1) gene on fetal hemoglobin induction in sickle cell anemia patients.

Authors:  Priya Hariharan; Vrushali Chavan; Anita Nadkarni
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.